ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2015

Is second-line systemic chemotherapy beneficial in patients with non-small cell lung cancer (NSCLC)? A multicenter data evaluation by the Anatolian Society of Medical Oncology.

Hatice Odabas et al.PubMed ↗Publisher ↗

No numbers read from the abstract.